DICE Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on DICE Therapeutics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how DICE Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with DICE Therapeutics Inc.

Back to companies

DICE Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on DICE Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into DICE Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Richard Scheller, PhD

Chairman Executive Board Since: 2015 Age: 71

Dr. Richard Scheller has been the Chairman of the company since 2015. Prior to this, he served as the Executive Vice President and Head of Genentech Research. Dr. Scheller also served as the Chairman of Research and Development of BridgeBio Pharma. Previously, he served as the Chief Scientific Officer and Head of Therapeutic Development at 23andMe.

Read Hide full bio of Richard Scheller, PhD

J. Kevin Judice, PhD

Chief Executive Officer Senior Management Since: 2013 Age: 62

Dr. J. Kevin Judice has been the Chief Executive Officer of the company since 2013. Prior to this, he served as the Chief Scientific Officer of Cidara Therapeutics Inc since 2012. Previously, he served as the Chief Scientific Officer and Chief Executive Officer at Achaogen Inc since 2004. Dr. Judice also served as the Senior Director, Medicinal Chemistry at Genentech Inc from 2002. Before that, he served as the Vice President of Chemistry at Theravance Biopharma Inc.

Read Hide full bio of J. Kevin Judice, PhD

John Jacobsen, PhD

Chief Scientific Officer Senior Management Since: 2021 Age: 57

Dr. John Jacobsen has been the Chief Scientific Officer of the company since 2021. Prior to this, he served as the Senior Vice President in Drug Discovery since 2019; and also served as the Senior Vice President in Chemistry 2015 of the company. Dr. Jacobsen also served in various roles including Senior Director in Medicinal Chemistry at Theravance Biopharma since 1998.

Read Hide full bio of John Jacobsen, PhD

Venkat Thalladi, PhD

Senior Vice President - Chemistry, Manufacturing & Controls Senior Management Since: 2021

Paul Fatheree

Senior Vice President - Medicinal Chemistry Senior Management Since: 2018
Gain a 360-degree view of DICE Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of DICE Therapeutics Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer